Incidence of Type 1, Type 2 Diabetes Increasing in People Younger Than 20

2023-03-31
FRIDAY, March 31, 2023 -- The incidence of type 1 and type 2 diabetes is increasing among children and young people aged 0 to 19 years, according to a study published in the April issue of The Lancet Diabetes & Endocrinology.
Lynne E. Wagenknecht, Dr.P.H., from Wake Forest University School of Medicine in Winston-Salem, North Carolina, and colleagues identified children and young people aged 0 to 19 years with a physician diagnosis of type 1 or type 2 diabetes at five U.S. centers between 2002 and 2018 to describe the incidence during a 17-year period.
The researchers identified 18,169 individuals aged 0 to 19 years with type 1 diabetes in 85 million person-years and 5,293 individuals aged 10 to 19 years with type 2 diabetes in 44 million person-years. The annual incidence of types 1 and 2 diabetes was 22.2 and 17.9 per 100,000, respectively, in 2017 to 2018. A linear effect and a moving-average effect were captured in the model for trend, with a significant increasing linear effect observed for types 1 and 2 diabetes (2.02 and 5.31 percent, respectively). Greater increases in the incidence of both types of diabetes were seen for children and youth from racial and ethnic-minority groups such as non-Hispanic Blacks and Hispanics. The peak age at diagnosis was 10 and 16 years for type 1 and type 2 diabetes, respectively. Diagnoses of type 1 diabetes peaked in January, while type 2 diabetes diagnoses peaked in August.
"These findings will help guide focused prevention efforts," Wagenknecht said in a statement. "Now that we have a better understanding of risk factors, our next phase of research will be studying the underlying pathophysiology of youth-onset diabetes."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Posted March 2023
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
机构
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。